Topical fluticasone propionate lotion does not cause HPA axis suppression
Open Access
- 30 September 2006
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 149 (3), 378-382
- https://doi.org/10.1016/j.jpeds.2006.05.008
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin DiseasesSkin Pharmacology and Physiology, 2004
- Diagnosis of Adrenal InsufficiencyAnnals of Internal Medicine, 2003
- Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group studyBMJ, 2003
- The use of corticosteroids and corticosteroid phobia in atopic dermatitisClinics in Dermatology, 2003
- Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patientsBritish Journal of Dermatology, 2002
- Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 monthsJournal of the American Academy of Dermatology, 2002
- Left-Right Comparison Study of the Combination of Fluticasone Propionate and UV-A vs Either Fluticasone Propionate or UV-A Alone for the Long-term Treatment of VitiligoArchives of Dermatology, 1999
- Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitisJournal of the American Academy of Dermatology, 1998
- Topical Fluticasone PropionateBioDrugs, 1997
- Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatmentBritish Journal of Dermatology, 1995